Latest Articles
Writer shares troubling story about invisible threat impacting neighborhood where she grew up: 'We lived in the shadow' - MSN
Writer shares troubling story about invisible threat impacting neighborhood where she grew up: 'We lived in the shadow' MSN
Published: June 3, 2025, 6:39 a.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo Finance
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo Finance
Published: June 2, 2025, 6:30 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo
Published: June 2, 2025, 6:30 p.m.
Bunnie Xo Considers Stopping IVF as She Endures Worst Side Effects Yet - k99.com
Bunnie Xo Considers Stopping IVF as She Endures Worst Side Effects Yet k99.com
Published: June 2, 2025, 4:30 p.m.
Bunnie Xo Considers Stopping IVF as She Endures Worst Side Effects Yet - Duluth Country Radio
Bunnie Xo Considers Stopping IVF as She Endures Worst Side Effects Yet Duluth Country Radio
Published: June 2, 2025, 4:30 p.m.
Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting - TradingView
Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting TradingView
Published: June 2, 2025, 11:30 a.m.
When doctors don’t believe their patients’ pain – experts explain the all-too-common experience of medical gaslighting - Cobb Courier
When doctors don’t believe their patients’ pain – experts explain the all-too-common experience of medical gaslighting Cobb Courier
Published: June 2, 2025, 10:07 a.m.
Deeply Infiltrating Endometriosis (DIE) No More: Dienogest as a Game Changer in Rectovaginal Endometriosis - Cureus
Deeply Infiltrating Endometriosis (DIE) No More: Dienogest as a Game Changer in Rectovaginal Endometriosis Cureus
Published: June 1, 2025, 7:24 a.m.
Link copied to clipboard!